Serum Concentrations of S100B and Neurofilament Light Chain as Biomarkers for Checkpoint Inhibitor–Induced CNS Inflammation
Sara Bjursten(Sahlgrenska University Hospital), MAX LEVIN(Sahlgrenska University Hospital), Ankur Pandita(Sahlgrenska University Hospital), Anna Rudin(Centre for Inflammation Research), Zhiyuan Zhao(Sahlgrenska University Hospital), Joel Simrén(University of Gothenburg), Henrik Zetterberg(University of Wisconsin System), Lars Ny(Sahlgrenska University Hospital)
Cited by 0
Related Papers
Neuroinflammation in Alzheimer disease
|Nature reviews. Immunology|2024|401
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
|Alzheimer s & Dementia|2021|354
Survival Outcomes in Patients With Previously Untreated <i>BRAF</i> Wild-Type Advanced Melanoma Treated With Nivolumab Therapy
|JAMA Oncology|2018|345
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
|Alzheimer s & Dementia|2021|238
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change
|Acta Neuropathologica|2022|229